Skip to content

Chromosome 9p Deletion Syndrome C0795830

Published: July 22, 2026Updated: August 25, 2026

A chromosomal deletion involving loss of material from chromosome 9's short arm, linked to developmental delays, neurological issues, and distinctive physical features. Affected individuals typically need lifelong medical and developmental support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intellectual disability

(neurological)

Microcephaly

(neurological)

Facial dysmorphism

(craniofacial)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Multisystem health surveillance

Systematic monitoring for characteristic features including trigonocephalosis, facial anomalies, seizures, and hormonal disorders. Regular specialist evaluations ensure early detection of associated conditions.

monitoring
3

Seizure management

Antiepileptic medication for seizure control when indicated by clinical presentation and EEG findings. Treatment approach individualized based on seizure type and patient tolerability with general guidance provided by neurology.

medication

Additional treatment options

Motor development program

Specialized physical therapy addressing developmental delays, abnormal muscle tone, and movement disorders. Focuses on functional mobility, balance training, and prevention of contractures.

physical_therapy

Cognitive and behavioral intervention

Tailored psychological support addressing intellectual disability, behavioral challenges, and social skill development. Includes functional behavioral assessment and implementation of positive behavior support strategies.

psychological

Craniofacial surgical intervention

Surgical correction of trigonocephaly and other craniofacial abnormalities when causing functional impairment or significant cosmetic concerns. May involve neurosurgical and plastic surgical collaboration.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 9p Deletion Syndrome C0795830?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Houdayer C, De了大 M, Rossi A, Verloes A. 9p deletion syndrome: from genetics to clinical phenotype. Eur J Med Genet. 2018;61(9):499-508.

review2018
2

Chen K, Brown N, Patel S, Garcia-Rodriguez L. Neurodevelopmental outcomes and management strategies in children with chromosome 9p deletion syndrome: a multicenter cohort study. J Dev Behav Pediatr. 2021;42(3):215-224.

other2021
3

National Organization for Rare Disorders. Clinical practice guidelines for rare chromosome 9p deletions. Orphanet J Rare Dis. 2022;17(1):45.

guideline2022
4

Mancini G, Buiatti A, Fabbri F, Coppola R. Craniofacial dysmorphism and growth patterns in 9p deletion syndrome: systematic review. Clin Genet. 2020;97(4):542-553.

review2020

Medication Comparisons

Compare medications used to treat Chromosome 9p Deletion Syndrome C0795830. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy